According to a recent article, patients with recurring kidney cancer who would most likely need to get their kidney removed can now possibly keep their organ thanks to a new treatment.
Kidney cancer is cancer that begins in the kidneys, as the name suggests. Your kidneys are two bean-shaped organs, each about the size of your fist. They’re located behind your abdominal organs, with one kidney on each side of your spine.
Kidney cancer usually doesn’t have signs or symptoms in its early stages. In time, signs and symptoms may develop, including:
- Blood in your urine, which may appear pink, red, or cola colored
- Pain in your back or side that doesn’t go away
- Loss of appetite
- Unexplained weight loss
After his patient’s kidney cancer came back five times, Dr. Ravi Munver of Hackensack University Medical Center, decided to try a treatment with JELMYTO.
JELMYTO is an FDA approved treatment that combines the chemotherapy drug, called mitomycin, and a chilled liquid that enters the body through the use of a catheter. The liquid turns into gel form as it warms to the temperature of the body. After a few hours, the hardened gel will pass through the patient’s system naturally.
Munver kept his patient on this treatment for six weeks, with his patient receiving the treatment once weekly. Four months after treatment, the patient had zero signs of any tumor regrowth. The chemo gel managed to eliminate the patient’ cancer and save their kidney.
JELMYTO is FDA approved and indicated only in patients who are diagnosed with non-aggressive, early-stage cancer.